Adverum Biotechnologies (ADVM)

Adverum Biotechnologies (ADVM) Financial Statements


Adverum Biotechnologies Financial Overview

Adverum Biotechnologies's market cap is currently ―. The company's EPS TTM is $-1.462; its P/E ratio is -1.01; Adverum Biotechnologies is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 3.60M-$ 0.00$ 0.00$ 0.00
Gross Profit$ 3.60M$ 4.10M---
EBIT$ -30.24M$ -33.94M$ -41.04M$ -44.02M$ -38.13M
EBITDA$ -28.18M$ -32.83M$ -39.25M$ -42.42M$ -36.71M
Net Income Common Stockholders$ -28.32M$ -32.34M$ -40.13M$ -43.76M$ -37.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 164.28M$ 185.59M$ 203.26M$ 235.84M$ 271.06M
Total Assets$ 275.58M$ 308.37M$ 332.36M$ 374.95M$ 407.39M
Total Debt$ 97.61M$ 106.80M$ 105.70M$ 105.48M$ 102.54M
Net Debt$ -66.67M$ -78.79M$ -97.56M$ -130.36M$ -168.52M
Total Liabilities$ 117.82M$ 126.85M$ 124.03M$ 130.83M$ 124.44M
Stockholders Equity$ 157.76M$ 181.52M$ 208.34M$ 244.12M$ 282.95M
Cash Flow-
Free Cash Flow$ 2.50M-$ -32.63M$ -35.31M$ -33.30M
Operating Cash Flow$ 2.50M-$ -31.81M$ -28.88M$ -28.93M
Investing Cash Flow$ 21.53M-$ 24.37M$ 30.73M$ 84.38M
Financing Cash Flow--$ 0.00$ 362.00K$ 3.00K
Currency in USD

Adverum Biotechnologies Earnings and Revenue History

Adverum Biotechnologies Debt to Assets

Adverum Biotechnologies Cash Flow

Adverum Biotechnologies Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis